Skip to main content
Log in

Summary

Pharmacokinetic studies with orally administered 14C-oxyfedrine were carried out in rats and also in men.

  1. 1.

    In the rat tissue concentrations of oxyfedrine (determined by UV absorption) and 14C-radioactivity reached a maximum within 15 min. Recovery of oxyfedrine equaled that of 14C-activity (14C-oxyfedrine + 14C-labelled metabolites) in the heart and lung tissues, but differed somewhat in the liver and kidney extracts.

  2. 2.

    In experiments with bile fistula rats, 3 metabolites were recovered in the bile: a main metabolite, as an unlabeled, ninhydrin-positive substance (M1) besides two 14C-labeled minor metabolites*.

  3. 3.

    Approximately 40 to 50% of the oxyfedrine applied appeared in the urine as metabolites of oxyfedrine, mainly norephedrine, in rats and men.

  4. 4.

    The pharmacological significance of these findings is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Hahn, N., Felix, R., Draznin, N., Meuser, H. J., Düx, A.: Die Wirkung von Oxyfedrin auf die Durchblutung der Coronargefäße im intra- und extramuralen Bereich (Untersuchungen am Hund). Arzneimittel-Forsch. 19, 300–304 (1969).

    Google Scholar 

  • Hüdepohl, M.: Koronartherapie mit Ildamen. Münch. med. Wschr. 108, 2360–2364, (1966).

    Google Scholar 

  • Kirsch, U., Autenrieth, G., Hymmen, D. von: Vergleichende Untersuchungen über die Wirkung von Dipyridamol, Oxyfedrin, Ajmalin, Propranolol und Verapamil auf die hypotherme Flimmerschwelle des Merschweinchenherzens. Arzneimittel-Forsch. 19 654–656 (1969).

    Google Scholar 

  • Krautheim, J., Schmid, E.: Untersuchungen zum Wirkungsmechanismus eines neuen herzwirksamen β-Aminoketons. Arzneimittel-Forsch. 16, 1500–1502 (1966).

    Google Scholar 

  • Kukovetz, W. R., Pöch, G.: Erregung adrenerger β-Receptoren in den Herzen normaler und reserpinisierter Meerschweinchen durch Oxyfedrin. Arzneimittel-Forsch. 19, 1562–1566 (1969).

    Google Scholar 

  • Miller, L. L., Bly, C. C., Watson, M. L., Bale, W. F.: The dominant role of the liver in plasma protein synthesis. J. exp. Med. 94, 431–453 (1951).

    Google Scholar 

  • Moll, A., Petzel, H.: Experimentelle und klinische Untersuchungen mit einer neuen koronar- und herzwirksamen Substanz. Z. Kreislauf-Forsch. 56, 46–58 (1967).

    Google Scholar 

  • Niessner, H., Lujf, A., Moser, K.: Experimentelle Untersuchungen zur Beeinflussung des Myokardstoffwechsels durch Oxyfedrin. Z. ges. exp. Med. 151, 163–174 (1969).

    Google Scholar 

  • Raab, W.: The nonvascular metabolic myocardial vulnerability factor in “coronary heart disease”. Amer. Heart J. 66, 685–706 (1963).

    Google Scholar 

  • Raab, W.: The neurogenic metabolic factor in ischemic heart disease. Dis. Chest. 46, 150–157 (1964).

    Google Scholar 

  • Sakai, K.: β-Adrenergic blocking property of l-3-methoxy-ω-(1-hydroxy-1-phenyl-isopropylamino)propiophenone·HCl (D 563) in femoral circulation. Jap. J. Pharmacol. 20, 306–307 (1970).

    Google Scholar 

  • Sansone, M., Dell'Omodarme, G., Sorrentino, L.: Attivita coronaro-dilatatrice di derivati beta-fenilpropiofenonici. Arch. ital. Sci. farmacol. 13, 249–252 (1963).

    Google Scholar 

  • Somani, P., Laddu, A. R.: Blockade of cardiac effects of isoproterenol by 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide (ICI-50, 172). J. Pharmacol. expt. Ther. 170, 72–78 (1969).

    Google Scholar 

  • Sternitzke, N., Köhler, J. A., Lang, E.: Der Einfluß von Ildamen, einem kardioenergetischen Koronar-Therapeutikum, auf die Herz- und Kreislaufdynamik. Med. Welt. 17, 1910–1915 (1966).

    Google Scholar 

  • Thiele, K., Schimassek, U., Schlichtegroll, A. von: Neue herzwirksame β-Aminoketone. Arzneimittel-Forsch. 16, 1064–1067 (1966).

    Google Scholar 

  • Thiemer, K., Stadler, R.: Biochemische, Untersuchungen über l-3-Methoxy-ω-(1-hydroxy-1-phenylisopropylamino)propiophenon Hydrochlorid. Arzneimittel-Forsch. 16, 1502–1505 (1966).

    Google Scholar 

  • Thiemer, K., Stadler, R., Schlichtegroll, A. von: Biochemisch-pharmakologische Untersuchungen über ein neues auf Myocard und Coronarien wirksames β-Aminoketon (Oxyfedrin). Arzneimittel-Forsch. 18, 388–396 (1968).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

By chemical and pharmacodynamic tests M1 proved to be identical with norephedrine.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sakai, K., Sugano, S., Watanabe, I. et al. Metabolism of oxyfedrine. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 323–337 (1972). https://doi.org/10.1007/BF00500060

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00500060

Key words

Navigation